11 junio 2026

Mastering f1/f2 Analysis with q‑doc

Discover how f1/f2 profile comparison transforms dissolution data into regulatory confidence. Learn why these metrics are essential for demonstrating product equivalence and how streamlined digital workflows in q‑doc software simplify complex analyses.

In today’s regulatory landscape, demonstrating equivalence between dissolution profiles is essential. The f1 (difference factor) and f2 (similarity factor) are the industry standard for comparing dissolution profiles of pharma­ceutical products. While the f1 factor quantifies the percentage difference between two profiles, the f2 factor provides a logarithmic measure of similarity – ensuring equivalent in vitro performance between test and reference products.

Performing a compliant f1/f2 comparison requires strict adherence to regulatory guidance. From ensuring identical testing conditions and synchronized time points to managing variability thresholds, each step must be carefully controlled and documented.

This is where q‑doc software adds value. It streamlines the entire workflow – from data generation to automated calculation and reporting – ensuring alignment with FDA expectations while reducing manual effort. The result: improved efficiency, data integrity, and confidence in your dissolution comparisons.

Download our comprehensive Application Note to explore the methodology, regulatory context, and step-by-step execution in q‑doc software.